Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse Effects of Sodium Colistimethate
Jan Koch‐Weser
Annals of Internal Medicine (1970) Vol. 72, Iss. 6, pp. 857-857
Closed Access | Times Cited: 436

Showing 1-25 of 436 citing articles:

Antibiotics and Bacterial Resistance in the 21st Century
Richard J. Fair, Yitzhak Tor
Perspectives in Medicinal Chemistry (2014) Vol. 6
Open Access | Times Cited: 1861
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
M. E. Falagas, S. K. Kasiakou, Louis D. Saravolatz
Clinical Infectious Diseases (2005) Vol. 40, Iss. 9, pp. 1333-1341
Open Access | Times Cited: 1586
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li, Roger L. Nation, John Turnidge, et al.
The Lancet Infectious Diseases (2006) Vol. 6, Iss. 9, pp. 589-601
Closed Access | Times Cited: 1336
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Laurent Poirel, Aurélie Jayol, Patrice Nordmann
Clinical Microbiology Reviews (2017) Vol. 30, Iss. 2, pp. 557-596
Open Access | Times Cited: 1230
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E Falagas, S. K. Kasiakou
Critical Care (2006) Vol. 10, Iss. 1
Open Access | Times Cited: 727
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Jian Li, Roger L. Nation, Robert Milne, et al.
International Journal of Antimicrobial Agents (2004) Vol. 25, Iss. 1, pp. 11-25
Closed Access | Times Cited: 553
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Martin E. Evans, David J. Feola, Robert P. Rapp
Annals of Pharmacotherapy (1999) Vol. 33, Iss. 9, pp. 960-967
Closed Access | Times Cited: 551
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas, Jean Michel Brunel, J.‐C. Dubus, et al.
Expert Review of Anti-infective Therapy (2012) Vol. 10, Iss. 8, pp. 917-934
Closed Access | Times Cited: 542
Polymyxins Revisited
David Landman, Claudiu Georgescu, Don Antonio Martin, et al.
Clinical Microbiology Reviews (2008) Vol. 21, Iss. 3, pp. 449-465
Open Access | Times Cited: 521
Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez, et al.
Clinical Infectious Diseases (2003) Vol. 36, Iss. 9, pp. 1111-1118
Open Access | Times Cited: 476
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
Maria Lina Mezzatesta, Floriana Gona, Stefania Stefani
Future Microbiology (2012) Vol. 7, Iss. 7, pp. 887-902
Closed Access | Times Cited: 475
Towards Understanding MCR-like Colistin Resistance
Jian Sun, Huimin Zhang, Ya-Hong Liu, et al.
Trends in Microbiology (2018) Vol. 26, Iss. 9, pp. 794-808
Closed Access | Times Cited: 398
Neurotoxic effects associated with antibiotic use: management considerations
Marie Grill, Rama Maganti
British Journal of Clinical Pharmacology (2011) Vol. 72, Iss. 3, pp. 381-393
Open Access | Times Cited: 359
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Phillip J. Bergen, Jian Li, Craig R. Rayner, et al.
Antimicrobial Agents and Chemotherapy (2006) Vol. 50, Iss. 6, pp. 1953-1958
Open Access | Times Cited: 352
Nosocomial Infections Due to Multidrug-ResistantPseudomonas aeruginosa: Epidemiology and Treatment Options
Marilee D. Obritsch, Douglas N. Fish, Robert MacLaren, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2005) Vol. 25, Iss. 10, pp. 1353-1364
Open Access | Times Cited: 346
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell, Robert Neff, Julie A. Ake, et al.
Clinical Infectious Diseases (2009) Vol. 48, Iss. 12, pp. 1724-1728
Open Access | Times Cited: 345
The Nephrotoxicity of Antimicrobial Agents
Gerald B. Appel, Harold C. Neu
New England Journal of Medicine (1977) Vol. 296, Iss. 13, pp. 722-728
Closed Access | Times Cited: 313
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Sue C. Nang, Mohammad Abul Kalam Azad, Tony Velkov, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 679-728
Open Access | Times Cited: 290
Multidrug-Resistant Gram-Negative Infections
Helen Giamarellou, Garyphallia Poulakou
Drugs (2009) Vol. 69, Iss. 14, pp. 1879-1901
Open Access | Times Cited: 280
Renal and neurological side effects of colistin in critically ill patients
Herbert Spapen, Rita Jacobs, Viola Van Gorp, et al.
Annals of Intensive Care (2011) Vol. 1, Iss. 1
Open Access | Times Cited: 259
Colistin: new lessons on an old antibiotic
Dafna Yahav, L. Farbman, Leonard Leibovici, et al.
Clinical Microbiology and Infection (2011) Vol. 18, Iss. 1, pp. 18-29
Open Access | Times Cited: 244
Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health
Boudewijn Catry, Marco Cavaleri, Keith E. Baptiste, et al.
International Journal of Antimicrobial Agents (2015) Vol. 46, Iss. 3, pp. 297-306
Closed Access | Times Cited: 224
The rise and spread ofmcrplasmid-mediated polymyxin resistance
Sue C. Nang, Jian Li, Tony Velkov
Critical Reviews in Microbiology (2019) Vol. 45, Iss. 2, pp. 131-161
Open Access | Times Cited: 210
Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections
Yiyun Zhu, Weijing Hao, Xia Wang, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1377-1422
Closed Access | Times Cited: 159
Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis
Ulrike Binsker, Annemarie Käsbohrer, Jens A. Hammerl
FEMS Microbiology Reviews (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 121
Page 1 - Next Page

Scroll to top